Cargando…

Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents

BACKGROUND: Despite the significant impact of pharmaceutical innovations on healthcare, our understanding is still limited because previous studies explored only a few cases and largely came from a linear perspective. This study presents a detailed case of the Chinese and U.S. pharmaceutical patents...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Qiaolei, Luan, Chunjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118001/ https://www.ncbi.nlm.nih.gov/pubmed/30165885 http://dx.doi.org/10.1186/s12992-018-0408-z

Ejemplares similares

The U.S. medicine chest: Understanding the U.S. pharmaceutical supply chain and the role of the pharmacist
por: Costantino, Ryan C.
Publicado: (2021)

The effect of collaborative innovation on ICT-based technological convergence: A patent-based analysis
por: Hwang, Inyoung
Publicado: (2020)

The innovation value chain of patents: Breakthrough in the patent commercialization trap in Chinese universities
por: Gong, Hong, et al.
Publicado: (2020)

The procurement of innovation by the U.S. government
por: de Rassenfosse, Gaétan, et al.
Publicado: (2019)

Patently Innovative
por: Bouchard, R
Publicado: (2012)

Comparative overview of innovation and patent filings in Radiopharmacy
por: Miranda, Ana Cláudia Camargo, et al.
Publicado: (2019)

Marketable value estimation of patents using ensemble learning methodology: Focusing on U.S. patents for the electricity sector
por: Eom, Haneul, et al.
Publicado: (2021)

Obstacles and opportunities in Chinese pharmaceutical innovation
por: Ni, Jingyun, et al.
Publicado: (2017)

Guessability of U.S. pharmaceutical pictograms in Iranian prospective users
por: Saremi, Mahnaz, et al.
Publicado: (2020)

Diffusion of an innovation: growth in video capsule endoscopy in the U.S. Medicare population from 2003 to 2019
por: Read, Andrew J., et al.
Publicado: (2022)

Value and Influencing Factors of the Cooperation, Convergence, and Harmonization in the Pharmaceutical Sector
por: Lezotre, Pierre-Louis
Publicado: (2014)

Identification of US-pharmaceutical patents expiring between 2018 and 2022 and their effect on the Brazilian domestic market
por: Paes, Thalita D.M., et al.
Publicado: (2020)

Predictors of loss due to pharmaceutical fraud: evidence from the U.S.
por: Timofeyev, Yuriy, et al.
Publicado: (2022)

Effect of Patent Expiry on the Performance of Innovator Multinational Pharmaceutical Companies in a Low Middle Income Country
por: Khalil, Farrukh, et al.
Publicado: (2022)

Patent relatedness and velocity in the Chinese pharmaceutical industry: A dataset of Jaccard similarity indices
por: Vorreuther, Charlotte Marie, et al.
Publicado: (2021)

A U. S. Patent on Antitoxin
Publicado: (1898)

Pharmaceutical patenting in the European Union: reform or riddance
por: Garattini, Livio, et al.
Publicado: (2021)

Management innovation in U.S. public water and wastewater systems /
Publicado: (2005)

Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration.
por: Zoon, K C
Publicado: (1999)

Unknown Organofluorine Mixtures in U.S. Adult Serum:Contribution from Pharmaceuticals?
por: Pennoyer, Emily H., et al.
Publicado: (2023)

Mexican, U.S. relations : conflict and convergence /
Publicado: (1983)

Technological Innovations in Disease Management: Text Mining US Patent Data From 1995 to 2017
por: Huang, Ming, et al.
Publicado: (2019)

Income convergence across the U.S. states: further evidence from new recent data
por: Ram, Rati
Publicado: (2020)

An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile
por: Abud, María José, et al.
Publicado: (2015)

Perverse Results from Pharmaceutical Patents in the United States
por: Grimes, Warren
Publicado: (2021)

Are Patents Impeding Medical Care and Innovation?
por: Gold, E. Richard, et al.
Publicado: (2010)

Russian Innovation in the Era of Patent Globalization
por: Lebedenko, Svitlana
Publicado: (2022)

U.S. cannabis laws projected to cost generic and brand pharmaceutical firms billions
por: Bednarek, Ziemowit, et al.
Publicado: (2022)

Rising to the challenges of the pandemic: Telehealth innovations in U.S. emergency departments
por: Uscher-Pines, Lori, et al.
Publicado: (2021)

Differential diffusion of pharmaceutical innovations in a mixed market middle - income economy
por: Md Hamzah, Nurhafiza, et al.
Publicado: (2021)

Association Between Length of Residence in the U.S. and Insurance Coverage Within U.S. Chinese Older Adults
por: Tuseth, Natalie, et al.
Publicado: (2021)

Association Between Length of Residence in the U.S. and Insurance Coverage Within U.S. Chinese Older Adults
por: Tuseth, Natalie, et al.
Publicado: (2021)

When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic
por: Ozyhar, Tomasz, et al.
Publicado: (2022)

Convergence of COVID-19 and chronic air pollution risks: Racial/ethnic and socioeconomic inequities in the U.S
por: Chakraborty, Jayajit
Publicado: (2021)

Understanding the Pathways of Neighborhood Environmental Influences on Health Among U.S. Chinese Older Immigrants
por: Wang, Yi, et al.
Publicado: (2020)

Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
por: Gurgula, Olga
Publicado: (2020)

Pharmaceutical patents: reconciling the human right to health with the incentive to invent
por: Khachigian, Levon M.
Publicado: (2020)

Dynamics of price competition in Italian pharmaceutical off-patent market
por: Perna, Serena, et al.
Publicado: (2022)

Implications of Patent Pools on Innovation Regarding Antiretrovirals
por: Noehrenberg, Eric
Publicado: (2010)

Power Law Distributions of Patents as Indicators of Innovation
por: O’Neale, Dion R. J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6jihd9k6cuq0ru88rkqdl2qsao